Table: Kringle Pharma - 6-MTH parent results

Kringle Pharma

11/05/2026 07:40

May 11 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Mar 31, 2026        Mar 31, 2025       Sep 30, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            36 mln              35 mln            332 mln     
                 (+2.2 pct)          (-16.5 pct)       (+360.4 pct)  
  Operating     loss 515 mln        loss 511 mln        loss 1.02    
  Recurring     loss 513 mln        loss 511 mln        loss 1.02    
  Net           loss 516 mln        loss 512 mln        loss 1.02    
  EPS          loss 71.37 yen      loss 75.15 yen    loss 139.41 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T